Quarterly News

Historical Moves

Analysts POV

Regeneron Pharmaceuticals (REGN) Stock Analysis: A Deep Dive into a Science-First Biopharma

For over three decades, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has forged a unique path in the biotechnology industry. Founded on a science-first philosophy and a deep commitment to proprietary technology platforms, the company has built a reputation for developing innovative…

Qualcomm (QCOM) Stock Analysis: The King of Mobile Chips Pivots to the Future

Qualcomm Incorporated (NASDAQ: QCOM) is a company that has been a silent but essential architect of the modern wireless world. Its name may not be as widely recognized by consumers as Apple or Samsung, but its technology is at the…

Netflix (NFLX) Stock Analysis: Navigating the Streaming Wars and a New Era of Profitability

Netflix, Inc. (NASDAQ: NFLX) is the company that pioneered the streaming revolution. It began as a scrappy DVD-by-mail service that dared to challenge the dominance of video rental stores and cable television. In the two decades since, it has transformed…

Gilead Sciences (GILD) Stock Analysis: A Deep Dive into the Biotech Giant’s Oncology Pivot

Gilead Sciences, Inc. (NASDAQ: GILD) is a name synonymous with some of the most significant medical breakthroughs of the last two decades. The company’s pioneering work in virology has transformed the treatment of diseases like HIV and hepatitis C, turning…

Cisco (CSCO) Stock Analysis: A Deep Dive into the Networking Titan’s Software Pivot

For over three decades, Cisco Systems, Inc. (NASDAQ: CSCO) has been the quiet, foundational engine of the digital world. Its routers and switches have formed the backbone of the internet, connecting billions of devices and enabling the flow of information…

Advanced Micro Devices (AMD) Stock Analysis: A Deep Dive into the Chipmaking Challenger

Advanced Micro Devices, Inc. (NASDAQ: AMD) is one of the most compelling and dramatic turnaround stories in modern corporate history. Just a decade ago, the company was on the brink of irrelevance, struggling with a series of failed product launches…